Pine River Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-50,665
Closed -$18K 513
2016
Q3
$18K Hold
50,665
﹤0.01% 391
2016
Q2
$24 Buy
50,665
+10
+0% ﹤0.01% 393
2016
Q1
$69K Buy
+50,655
New +$69K ﹤0.01% 627

Pine River Capital Management's RXII Position: Q4 2016 in Review

Pine River Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 50,665 shares — an estimated $18K sold.

Pine River Capital Management first reported a position in RXII in Q1 2016 and held it in 3 quarters. The position peaked at $69K in Q1 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Pine River Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Pine River Capital Management sold 50,665 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $18K.
  • Pine River Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q1 2016 and held it in 3 quarters.
  • Pine River Capital Management's GALENA BIOPHARMA INC COM position peaked at $69K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.